High acceptability and viral suppression rate for first-Line patients on a dolutegravir-based regimen: An early adopter study in Nigeria. oleh Opeyemi Abudiore, Ikechukwu Amamilo, Jennifer Campbell, Williams Eigege, Joseph Harwell, James Conroy, Justus Jiboye, Folu Lufadeju, Carolyn Amole, Owens Wiwa, Damien Anweh, Oche Ochai Agbaji, Alani Sulaimon Akanmu